EN CN


Cell Based Assays

Return

2D Cell-based Assays

2D Cell-Based Assays

Cell viability, proliferation and colony-formation assays provide practical readouts of compound effects on cellular health, growth and survival across drug discovery, toxicity testing and cancer research.

For regular large-scale tumor-cell screening, explore our ICECP™ cancer cell panel screening service ↗.

Applications

Decision-relevant cellular readouts

01 / DRUG DISCOVERY

Evaluate cytotoxic effects of new chemical entities or biologics across tumor cells and gene-edited cell models.

02 / TOXICITY TESTING

Assess compound effects on cell viability and proliferation to help define a safety profile.

03 / CANCER RESEARCH

Study anticancer-agent activity through cell proliferation and colony-formation endpoints.

04 / MECHANISTIC STUDIES

Investigate cell-cycle progression, DNA synthesis and long-term survival following therapeutic intervention.

Model Availability

Cell-model breadth for diverse programs

550+

Cancer cell lines for viability assays

450+

Cancer cell lines for clonogenic assays

80+

Engineered cell lines

30+

Resistant cell lines

50+

Normal cell lines

Assay Features

Select the readout aligned to your study question

01 / CELL VIABILITY

CellTiter-Glo: ATP-based measurement of metabolically active cells. CellTiter-Blue: resazurin reduction to measure viable-cell number. MTT: formazan formation from MTT reduction. CCK-8: WST-8 colorimetric assessment. Nuclear stains: fluorescent distinction of live and dead cells.

02 / CELL PROLIFERATION

CyQUANT: cellular DNA content as a proliferation readout. BrdU incorporation: newly synthesized DNA in proliferating cells.

03 / COLONY FORMATION

Crystal violet staining: visualizes and quantifies colonies formed by individual cells to assess clonogenic survival and proliferative capacity.

Study Formats

Flexible formats from screening to long-term survival

01 / 2D ASSAY FORMAT

96- or 384-well plate assays for high-throughput screening, including short-term 3–6 day or long-term 7–14 day proliferation studies.

02 / CLONOGENIC ASSAY

24-, 12- or 6-well formats support detailed colony-formation analysis over 10–14 days.

03 / CUSTOMIZED DESIGN

Assay configurations can support single-agent testing, combination studies, and programs requiring scalable throughput.


Contact Us

We value your inquiries and are here to provide you with tailored solutions for your drug discovery and development needs. Whether you have questions, require more information, or are interested in discussing potential collaborations, our team of experts is just a message away.
Feel free to reach out to us.

We are a CRO service organization, not a hospital




Get a quote

Go top